This inventor holds 1 USPTO granted patent and 11 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Sangamo Therapeutics, Inc., Sigma-Aldrich Co. LLC. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 154 
1 out of 142 Years Active: 2019
Title: Qiaohua Kang: Innovator in Gene Disruption Technologies
Introduction
Qiaohua Kang is a notable inventor based in Saint Louis, MO (US). He has made significant contributions to the field of genetic engineering, particularly in the area of nuclease-mediated gene disruption. His innovative work has implications for various applications in biotechnology and medicine.
Latest Patents
Qiaohua Kang holds a patent titled "Methods and compositions for enhancing nuclease-mediated gene disruption." This patent focuses on methods and compositions that enhance nuclease-mediated genomic modification using DNA repair inhibitors. His work in this area is crucial for advancing genetic modification techniques.
Career Highlights
Throughout his career, Qiaohua Kang has worked with prominent companies such as Sangamo Therapeutics, Inc. and Sigma-Aldrich Co. LLC. His experience in these organizations has allowed him to develop and refine his expertise in genetic engineering and biotechnology.
Collaborations
Qiaohua has collaborated with notable colleagues, including Fuqiang Chen and Thomas Wechsler. These partnerships have contributed to the advancement of his research and innovations in the field.
Conclusion
Qiaohua Kang's contributions to gene disruption technologies highlight his role as an influential inventor in the biotechnology sector. His patent and collaborations reflect his commitment to advancing genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile